The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. (Q42815809)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2005

Language	Label	Description	Also known as
English	The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice.	scientific article published on May 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Federica Cavallo

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Cristina Mastini

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Guido Forni

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Piero Musiani

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Leah N Klapper

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Britta Hardy

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

3280-3287

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Cancer immunoprevention: tracking down persistent tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Prophylactic cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Immunological inhibition of carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Activation of lymphocytes by BAT and anti CTLA-4: comparison of binding to T and B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Complementary antitumor immunity induced by plasmid DNA encoding secreted and cytoplasmic human ErbB-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Cure of Mammary Carcinomas in Her-2 Transgenic Mice through Sequential Stimulation of Innate (Neoadjuvant Interleukin-12) and Adaptive (DNA Vaccine Electroporation) Immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

CD4+ T lymphocytes as a primary cellular target for BAT mAb stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Prevention of breast tumour development in vivo by downregulation of the p185neureceptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.086

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.01.086

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837233%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42815809&oldid=2131857512"